← Back to headlines
Grifols Launches Biopharma Division on Wall Street
Spanish pharmaceutical company Grifols is listing its Biopharma division on Wall Street in a strategic move to boost its stock and reduce corporate debt.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippines Anticipates Significant Fuel Price Hikes by End of March
just now
Defense Stocks Rise, Auto and Shipbuilder Stocks Fall Amid Middle East Tensions
31m ago
Partners Group Faces Growing Criticism Over Kinder-Care Scandals
2h ago
Prediction: Two Stocks Projected to Outperform Apple in a Decade
2h ago